Candidate Compound Prioritization
Candidate Compound Prioritization is a computational or analytical method that ranks potential bioactive molecules according to their likelihood of favorable pharmacological properties and developability, thereby distinguishing itself from other drug-likeness assessment approaches by focusing explicitly on the sequential ordering of compounds to expedite the selection of optimal candidates for further experimental evaluation.
91
Publications
4.4K
Citations
513
Authors
202
Institutions
Publications per year
2017–2026
27
Parents
91
An Aggregation Advisor for Ligand Discovery
John J. Irwin, Da Duan, Hayarpi Torosyan et al. · Journal of Medicinal Chemistry · 2015 · 429 citations · Full text
Michael P. Pollastri · Current Protocols in Pharmacology · 2010 · 237 citations
1–5 of 91
513
7
h-index
4
h-index
4
h-index
3
h-index
3
h-index
1–5 of 513
202
University of Bonn
Bonn, Germany
5 h-index
13 publications
426 citations
Novartis (Switzerland)
Basel, Switzerland
5 h-index
17 publications
1.5K citations
Osmania University
Hyderabad, India
4 h-index
9 publications
132 citations
Pfizer (United States)
New York, United States
3 h-index
29 publications
2.9K citations
University of Washington
Seattle, United States
3 h-index
16 publications
361 citations
Morgridge Institute for Research
Madison, United States
3 h-index
7 publications
287 citations
Novartis Institutes for BioMedical Research
Basel, Switzerland
3 h-index
8 publications
1.4K citations
University of Wisconsin–Madison
Madison, United States
3 h-index
22 publications
662 citations
1–8 of 202
JCIM · 11 publications · 865 citations
10
h-index
7 publications · 719 citations
7
h-index
4 publications · 58 citations
4
h-index
4 publications · 239 citations
4
h-index
3 publications · 46 citations
3
h-index
1–5